Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial
JAMA Dermatol 2021 Oct 13;[EPub Ahead of Print], KM Harris, DE Smilek, M Byron, N Lim, WT Barry, J McNamara, S Garcet, RJ Konrad, M Stengelin, P Bathala, NJ Korman, SR Feldman, EE Boh, K Barber, AE Laumann, YR Helfrich, GG Krueger, H Sofen, R Bissonnette, JG KruegerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.